207 related articles for article (PubMed ID: 17130941)
1. [Potential cost effectiveness of a rotavirus vaccine in Chile].
Constenla D; O'Ryan M; Navarrete MS; Antil L; Rheingans RD
Rev Med Chil; 2006 Jun; 134(6):679-88. PubMed ID: 17130941
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.
Patel HD; Roberts ET; Constenla DO
Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497
[TBL] [Abstract][Full Text] [Related]
3. Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries.
Rheingans RD; Constenla D; Antil L; Innis BL; Breuer T
Rev Panam Salud Publica; 2007 Apr; 21(4):205-16. PubMed ID: 17612464
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.
Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ;
Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of rotavirus vaccination programs in Taiwan.
Chang WC; Yen C; Chi CL; Wu FT; Huang YC; Lin JS; Huang FC; Tate JE; Wu HS; Hsiung CA
Vaccine; 2013 Nov; 31(46):5458-65. PubMed ID: 24060569
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of childhood rotavirus vaccination in Germany.
Aidelsburger P; Grabein K; Böhm K; Dietl M; Wasem J; Koch J; Ultsch B; Weidemann F; Wichmann O
Vaccine; 2014 Apr; 32(17):1964-74. PubMed ID: 24561052
[TBL] [Abstract][Full Text] [Related]
8. Economic impact of a rotavirus vaccination program in Mexico.
Constenla D; Velázquez FR; Rheingans RD; Antil L; Cervantes Y
Rev Panam Salud Publica; 2009 Jun; 25(6):481-90. PubMed ID: 19695142
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of a pentavalent rotavirus vaccine in Oman.
Al Awaidy ST; Gebremeskel BG; Al Obeidani I; Al Baqlani S; Haddadin W; O'Brien MA
BMC Infect Dis; 2014 Jun; 14():334. PubMed ID: 24941946
[TBL] [Abstract][Full Text] [Related]
10. [Economic impact of rotavirus vaccination in Panama].
Constenla D; Ortega-Barría E; Rheingans RD; Antil L; Sáez-Llorens X
An Pediatr (Barc); 2008 Feb; 68(2):128-35. PubMed ID: 18341878
[TBL] [Abstract][Full Text] [Related]
11. Economic impact of a rotavirus vaccine in Brazil.
Constenla DO; Linhares AC; Rheingans RD; Antil LR; Waldman EA; da Silva LJ
J Health Popul Nutr; 2008 Dec; 26(4):388-96. PubMed ID: 19069617
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data.
Bar-Zeev N; Tate JE; Pecenka C; Chikafa J; Mvula H; Wachepa R; Mwansambo C; Mhango T; Chirwa G; Crampin AC; Parashar UD; Costello A; Heyderman RS; French N; Atherly D; Cunliffe NA;
Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S220-8. PubMed ID: 27059360
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran.
Javanbakht M; Moradi-Lakeh M; Yaghoubi M; Esteghamati A; Mansour Ghanaie R; Mahmoudi S; Shamshiri AR; Zahraei SM; Baxter L; Shakerian S; Chaudhri I; Fleming JA; Munier A; Baradaran HR
Vaccine; 2015 May; 33 Suppl 1():A192-200. PubMed ID: 25919160
[TBL] [Abstract][Full Text] [Related]
14. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.
Rheingans RD; Antil L; Dreibelbis R; Podewils LJ; Bresee JS; Parashar UD
J Infect Dis; 2009 Nov; 200 Suppl 1():S16-27. PubMed ID: 19817595
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.
Itzler RF; Chen PY; Lac C; El Khoury AC; Cook JR
J Med Econ; 2011; 14(6):748-58. PubMed ID: 21919673
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of the economic impact of the antiretroviral vaccine in Venezuela].
Constenla D; Pérez-Schael I; Rheingans RD; Antil L; Salas H; Yarzábal JP
Rev Panam Salud Publica; 2006 Oct; 20(4):213-22. PubMed ID: 17316479
[TBL] [Abstract][Full Text] [Related]
17. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria.
Anderson JD; Pecenka CJ; Bagamian KH; Rheingans RD
PLoS One; 2020; 15(5):e0232941. PubMed ID: 32469927
[TBL] [Abstract][Full Text] [Related]
18. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS
J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study.
Lee H; Park SY; Clark A; Debellut F; Pecenka C; Kim DS; Kim HM; Kim JH; Cho H; Kim AY; Lee M; Jung SY; Seong BL; Kang HY
Vaccine; 2019 Aug; 37(35):4987-4995. PubMed ID: 31326252
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: a model-based evaluation.
Fisman DN; Chan CH; Lowcock E; Naus M; Lee V
Vaccine; 2012 Dec; 30(52):7601-7. PubMed ID: 23107595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]